Skip to main content

Table 9 Clinicopathological characteristics of 78 PDAC patients

From: Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance

Gender  
Male 44 (56%)
Female 34 (44%)
T category  
T1 14 (18%)
T2 26 (33%)
T3 28 (36%)
T4 10 (13%)
N category  
NO 34 (44%)
N1 44 (56%)
M category  
M0 70 (90%)
M1 8 (10%)
Tumour size  
≥2 cm 42 (54%)
<2 cm 36 (46%)
Histology  
Well or moderately differentiated 38 (49%)
Poorly differentiated 40 (51%)
Perineural invasion  
None or slight 46 (59%)
Prominent 32 (41%)
Venous invasion  
None or slight 40 (51%)
Prominent 38 (49%)
Tumour grade (UICC)  
Stage I-IIA 32 (41%)
Stage IIB-IV 46 (59%)
Resection margin status  
R0 32 (41%)
R1 46 (59%)